Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Aug 29;14:161. doi: 10.1007/s12672-023-00765-5

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2023

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 1 — The mRNA expression and protein expression of CAV1. A mRNA expression of CAV1 in pan-cancers. B The differentiated mRNA expression of CAV1 in TCGA-LGG, total 1675 samples (1152 normal + 523 tumor samples). C The differentiated mRNA expression of CAV1 in TCGA-GBMLGG, total 1846 samples (1152 normal + 689 tumor samples + 5 tumor adjacent samples). D The differentiated mRNA expression of CAV1 in TCGA-LGG, total 1323 samples (1152 normal + 166 tumor samples + 5 tumor adjacent samples). E The protein expression of CAV1 in normal brain tissues (left) and glioma (right) with antibody HPA049326. F The protein expression of CAV1 in normal brain tissues (left) and glioma (right) with antibody CAB003791. G. The expression of CAV1 in different stages in LGG. H The expression of CAV1 in different stages of GBMLGG. I The protein expression of CAV1 in GBM and normal, data from UALCAN (can.path.uab.edu/). J–M. Single cell sequencing of GBM sample GSE 131928. N–Q Single cell sequencing of GBM sample GSE148842. *p value < 0.05; **p value < 0.01; ***p value < 0.001. OS: overall survival, DFS: disease-free survival

Fig. 1 — The mRNA expression and protein expression of CAV1. A mRNA expression of CAV1 in pan-cancers. B The differentiated mRNA expression of CAV1 in TCGA-LGG, total 1675 samples (1152 normal + 523 tumor samples). C The differentiated mRNA expression of CAV1 in TCGA-GBMLGG, total 1846 samples (1152 normal + 689 tumor samples + 5 tumor adjacent samples). D The differentiated mRNA expression of CAV1 in TCGA-LGG, total 1323 samples (1152 normal + 166 tumor samples + 5 tumor adjacent samples). E The protein expression of CAV1 in normal brain tissues (left) and glioma (right) with antibody HPA049326. F The protein expression of CAV1 in normal brain tissues (left) and glioma (right) with antibody CAB003791. G. The expression of CAV1 in different stages in LGG. H The expression of CAV1 in different stages of GBMLGG. I The protein expression of CAV1 in GBM and normal, data from UALCAN (can.path.uab.edu/). J–M. Single cell sequencing of GBM sample GSE 131928. N–Q Single cell sequencing of GBM sample GSE148842. *p value < 0.05; **p value < 0.01; ***p value < 0.001. OS: overall survival, DFS: disease-free survival